Press Release November 18, 2021Merck Provides Update on Phase 2 Clinical Trial of Once-Weekly Investigational Combination of MK-8507 and Islatravir for the Treatment of People Living with HIV-1 0 0 Share
Press Release November 18, 2021FDA Approves Merck's KEYTRUDA® (pembrolizumab) as Adjuvant Therapy for Certain Patients With Renal Cell Carcinoma (RCC) Following Surgery 0 0 Share
Press Release November 18, 2021Merck's Keytruda Scores First Approval In Adjuvant Kidney Cancer Setting 0 0 Share
Press Release November 17, 2021These 2 Covid pills could be available soon — and they might help end the pandemic. Here's how 0 0 Share
Company Ticker News November 15, 2021Second Half Of November Brings Dividend Increases From Merck, Nike And 12 Others 0 0 Share
Company Ticker News November 13, 2021Merck's Plan B Percolates After Pfizer Announces Dominance 0 0 Share
Company Ticker News November 12, 2021Is Merck's Planned Acquisition of Acceleron in Trouble? 0 0 Share
Company Ticker News November 11, 2021Merck (MRK) Inks $1.2B COVID-19 Pill Supply Deal With Japan 0 0 Share
Company Ticker News November 11, 2021MERCK Kommanditgesellschaft auf Aktien (MKGAF) CEO Belén Garijo on Q3 2021 Results - Earnings Call Transcript 0 0 Share
Company Ticker News November 11, 2021How Will Merck's Stock Forecast Be Impacted By U.K.'s COVID Pill Authorization? 0 0 Share
